Related Experiment Video
Updated: May 14, 2026
Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser
Published on: May 5, 2020
A novel strategy of cancer therapy by enucleation
1Department of Internal Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. aguddati@partners.org
Abstract:
Current modalities of cancer therapy utilize different agents to block key steps involved in cell division. Newer agents also block specific parts of molecular pathways that are vital for survival of the cancer cells but cells may develop resistance to all these agents and their use may also be limited by toxic effects on healthy normal cells. There is increasing evidence that the seat of cancer may be located in cancer stem cells which seldom divide. This property protects them from most of the chemotherapeutic agents which act on dividing cells. Identification of markers for cancer stem cells has been difficult and targeted therapy towards them has been elusive. The hypothesis proposed here utilizes the phenomenon of enucleation that is commonly observed in maturing red blood cells. Specifically, by utilizing protein fragment complementation it proposes that cancer cells may be induced to undergo enucleation. The specific advantage of this system is that the cells lose their nucleus and hence the emergence of resistance is very unlikely. The system also utilizes the binding of cytoplasmic cancer specific proteins to render it specific to cancer cells. It has the advantage of potentially being effective in cancer stem cells which may be resistant to conventional modes of therapy.
Insights
This study proposes a novel cancer therapy that induces cancer cells to lose their nucleus, preventing resistance. This approach may overcome limitations of current treatments and target resilient cancer stem cells.
Area of Science:
- Oncology
- Molecular Biology
- Biotechnology
Background:
- Conventional cancer therapies target cell division but face resistance and toxicity.
- Cancer stem cells, which divide infrequently, are protected from many chemotherapies.
- Targeting cancer stem cells remains challenging due to difficulties in identification and therapy development.
Purpose of the Study:
- To propose a novel therapeutic strategy inducing cancer cell enucleation.
- To develop a method for targeting cancer stem cells resistant to conventional treatments.
- To circumvent the development of therapeutic resistance in cancer cells.
Main Methods:
- Utilizing protein fragment complementation to trigger enucleation in cancer cells.
- Employing cancer-specific cytoplasmic proteins for targeted delivery.
- Leveraging the natural process of enucleation observed in maturing red blood cells.
Main Results:
- The proposed system induces cancer cells to undergo enucleation, expelling their nucleus.
- Cancer cells losing their nucleus are unlikely to develop resistance to this therapy.
- The system demonstrates specificity for cancer cells via cytoplasmic protein binding.
Conclusions:
- This enucleation-based therapy offers a potential strategy to overcome drug resistance in cancer.
- The approach may be effective against cancer stem cells, a known challenge in oncology.
- Targeting cancer cells for enucleation presents a promising avenue for novel cancer treatment development.
Related Concept Videos
01:27Tumor Immunotherapy
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...